Screen Reader Mode Icon

Review of home therapies provision in the context of COVID-19

Please respond for both home modalities – home haemodialysis (HHD) and peritoneal dialysis (PD)

Question Title

* 1. Please state the renal hospital you work at:

Question Title

* 2. What is your current role?

Question Title

* 3. Home Therapies Workforce:  Did your work-force change or be redeployed as a result of COVID-19 and what was the impact of this on home therapy care provision?

Question Title

* 4. Patient Training for Home Therapies (HHD and PD): Did you change or stop training patients to go home during COVID-19?

(What did you have to change about your training programmes and its delivery, what was the impact? What would have made a difference in terms of supporting patient training and getting patients safely home? How could they have been supported?)

Question Title

* 5. Industry providers of Home Therapies (HHD and PD): Did industry partners support and communicate with you during COVID-19?

 
(Was there anything industry could have done better, more of, less of?)

Question Title

* 6. Transplantation: Were those on a home therapy de-activated from the transplant list during the COVID-19 pandemic, or were all transplants stopped?  How did this impact your home therapies programme?

Question Title

* 7. Access: Was provision of access surgery limited due to COVID-19 and how did this impact on your home therapies programme? (please return on both PD and HD access)

Question Title

* 8. Access:  How have medical insertions made a difference to home therapy service delivery?

Question Title

* 9. Access: Are there plans for restoration of services?

Question Title

* 10. Decision Making: Have the risks of acquiring COVID-19 whilst dialysing in-centre changed your renal centre’s service planning with regards to provision of home dialysis (HHD and PD)?

Question Title

* 11. Decision Making: Have the risks of acquiring COVID-19 whilst dialysing in-centre changed the way decisions regarding treatment choice are reached / conversations are had between HCP and patients?

Question Title

* 12. Support:  How has the information, follow-up and support provided by your renal team to people dialysing at home changed during COVID-19?

 
(e.g. Use of technology to support home patients and the impact of use of Remote Patient Management)

Question Title

* 13. Beneficial changes: Are there any changes that have occurred that you would like to keep?

Question Title

* 14. Beneficial changes: Are there any changes you have not implemented but that you would like to make to ensure a safe and sustainable home therapies programme?

(What could have been done if anything to support units to maintain home programmes?)

Question Title

* 15. What would you like to stop/get rid of?

Question Title

* 16. Patient Feedback during COVID: Any patient feedback regarding Home Therapies (HHD and PD) captured during COVID both at the low clearance stage and also from those already on a home therapy?

0 of 16 answered
 

T